IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Blue Water Life Science Advisors, LP

Q4 2022 Holdings

Filed 2023-02-14 | 8 holdings | $148.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Natera Inc(NTRA)COM632307104$35.4M881,43623.8%
Guardant Health Inc(GH)COM40131M109$23.6M868,44515.9%
Adaptive Biotechnologies COR(ADPT)COM00650F109$23.2M3,030,43415.6%
Akoya Biosciences IncCOM00974H104$17.7M1,847,78511.9%
Maxcyte Inc(MXCT)COM57777K106$17.6M3,225,00011.8%
Cytek Biosciences Inc(CTKB)COM23285D109$13.3M1,300,0008.9%
Sonendo IncCOM835431107$13.1M4,643,4618.8%
Danaher Corporation(DHR)COM235851102$5.0M18,7503.3%